Panel discussion.

29 August 2020 (19:15 - 19:30)

Organised by:

Video

Sign in to view the resources

About the speakers

Doctor Kim Connelly

St. Michael's Hospital, Toronto (Canada)

Doctor Michael Lehrke

RWTH University Hospital Aachen, Aachen (Germany)

Doctor Neha Pagidipati

Duke Clinical Research Institute, Durham (United States of America)

4 More presentations in this session

Presentation thumbnail

Welcome and introduction.

Professor K. Connelly (Toronto, CA)

Presentation thumbnail

Highlighting cardiovascular benefits of glucagon-like peptide-1 receptor agonists.

Professor K. Connelly (Toronto, CA)

Presentation thumbnail

Evaluating cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists.

Doctor M. Lehrke (Aachen, DE)

Presentation thumbnail

Exploring the gap between data and clinical practice.

Assistant Professor N. Pagidipati (Durham, US)

Access the full session

Session thumbnail

Discussing clinical implications of glucagon-like peptide-1 receptor agonists

The Event

ESC Congress 2020

29 August 2020 19:15 CET

You may be interested in

Congress Session

Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

27 August 2023

Congress Presentation

Persistence and Adherence to GLP-1 RA treatment in Type 2 Diabetes Mellitus: a Nationwide registry study

31 August 2024

Congress Presentation

Prevalence of diabetic nephropathy and subsequent cardiovascular outcomes: a nationwide study of 74,014 patients with type 2 diabetes

28 August 2022

Congress Presentation

Panel discussion - GMRx2, QUADRO and VERONICA-Nigeria

31 August 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources